Zika virus infection is triggered by an Aedes mosquito-borne virus that bites during the day. In general, the symptoms include fever, rash, conjunctivitis, muscle and joint pain, malaise, or headache.
This report contains market size and forecasts of Zika Virus Therapeutic in Global, including the following market information:
Global Zika Virus Therapeutic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Zika Virus Therapeutic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Acetaminophen Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Zika Virus Therapeutic include Johnson and Johnson, Aurobindo Pharma, Granules India, Perrigo, Sun Pharmaceutical, Bharat Biotech, Emergent BioSolutions, Takeda Pharmaceutical and GeoVax Labs, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Zika Virus Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Zika Virus Therapeutic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Zika Virus Therapeutic Market Segment Percentages, by Type, 2021 (%)
Acetaminophen
Other NSAIDs
Global Zika Virus Therapeutic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Zika Virus Therapeutic Market Segment Percentages, by Application, 2021 (%)
Institutional Pharmacies
Retail Pharmacies
Others
Global Zika Virus Therapeutic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Zika Virus Therapeutic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Zika Virus Therapeutic revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Zika Virus Therapeutic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson and Johnson
Aurobindo Pharma
Granules India
Perrigo
Sun Pharmaceutical
Bharat Biotech
Emergent BioSolutions
Takeda Pharmaceutical
GeoVax Labs
IMV
Inovio Pharmaceuticals
Moderna
Merck
Valneva